Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Canqing Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0019-0014; OpenAlex author ID A5034779836. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 5

  1. [Establishment and identification of organoid derived from patients with pancreatic cancer based on suspension culture]. Co-author DOI 10.3760/cma.j.cn112152-20241004-00427↗
  2. Associations of diabetes, circulating protein biomarkers, and risk of pancreatic cancer. Co-author DOI 10.1038/s41416-023-02533-2↗
  3. Circulating proteins and risk of pancreatic cancer: a case-subcohort study among Chinese adults. Co-author DOI 10.1093/ije/dyab274↗
  4. Diabetes, plasma glucose and incidence of pancreatic cancer: A prospective study of 0.5 million Chinese adults and a meta-analysis of 22 cohort studies. Co-author DOI 10.1002/ijc.30599↗
  5. Young adulthood and adulthood adiposity in relation to incidence of pancreatic cancer: a prospective study of 0.5 million Chinese adults and a meta-analysis. Co-author DOI 10.1136/jech-2017-208895↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhengming Chen · 4 shared papers, 2017–2024 · strength 0.42
  2. Yuanjie Pang · 4 shared papers, 2017–2024 · strength 0.42
  3. Christiana Kartsonaki · 4 shared papers, 2017–2024 · strength 0.42
  4. Changpeng Chai · 1 shared paper, 2025 · strength 0.28
  5. Huijun Xu · 1 shared paper, 2025 · strength 0.28
  6. Michael Vaclav Holmes · 3 shared papers, 2017–2022 · strength 0.24
  7. Xiaoming Yang · 1 shared paper, 2024 · strength 0.18
  8. Eric O’Neill · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.